Latest Breaking News On - Merrimack pharmaceuticals inc - Page 1 : vimarsana.com

Merrimack Pharmaceuticals, Inc. (NASDAQ:MACK) Increases Dividend to $15.10 Per Share

Merrimack Pharmaceuticals, Inc. (NASDAQ:MACK – Get Free Report) announced a dividend on Thursday, May 16th, investing.com reports. Shareholders of record on Tuesday, May 21st will be paid a dividend of 15.10 per share by the biopharmaceutical company on Friday, May 17th. This represents a yield of 99.87%. The ex-dividend date is Monday, May 20th. This […]

Merrimack Pharmaceuticals (NASDAQ:MACK) Cut to "Sell" at StockNews.com

StockNews.com cut shares of Merrimack Pharmaceuticals (NASDAQ:MACK – Free Report) from a hold rating to a sell rating in a research report released on Monday morning. Merrimack Pharmaceuticals Trading Up 0.1 % Merrimack Pharmaceuticals stock opened at $15.13 on Monday. The firm has a market capitalization of $219.84 million, a P/E ratio of -189.13 and […]

Merrimack Pharmaceuticals, Inc. Announces Stockholder Approval of Plan of Dissolution And Cash Liquidating Dividend Amount of $15.10 Per Share of Common Stock

Merrimack Pharmaceuticals, Inc. Announces Stockholder Approval of Plan of Dissolution And Cash Liquidating Dividend Amount of $15.10 Per Share of Common Stock

Merrimack Pharmaceuticals Plans Liquidating Dividend

Merrimack Pharmaceuticals, Inc. Announces Anticipated Final Cash Dividend Amount of Initial Liquidating Distribution, Subject to Receipt of Stockholder Approval of Plan of Dissolution

Merrimack Pharmaceuticals Announces Notification of Plan to Voluntary Delist Common Stock on NASDAQ Subject to Receipt of Stockholder Approval of Plan of Dissolution

Merrimack Receives $225 Million Milestone Payment from Ipsen

Merrimack Receives $225 Million Milestone Payment from Ipsen

Special Meeting of Stockholders to Approve Plan of Dissolution Scheduled for Friday, May 10, 2024 at 10:00 a.m. Eastern Standard Time ...

Merrimack Receives $225 Million Milestone Payment from Ipsen